Patricia Hess is the Chief Operating Officer of CURE. She is responsible for ensuring our operational structure is poised to drive CURE’s strategic priorities while enabling a culture of teamwork and collaboration. She brings 2 decades of leadership experience in the biopharmaceutical sector leading talent strategy and operations for industry leaders. While at Amgen, she held human resources roles of increasing responsibility and led large scale multi-national teams and programs covering the areas of the Americas, Europe and Asia Pacific. At Kite Pharma (acquired by Gilead Sciences) Patricia was Global Head of Talent and was responsible for expansive talent growth following FDA and EMA approval for novel CAR T cell therapy. Patricia hired, led, and developed a high performing global team leading the talent expansion in US, Europe and Asia Pacific. Patricia developed operating plans and metrics to ensure an optimal operating structure to include strategic internal and external partnerships to deliver a consistent, reliable scalable workforce. Patricia attended Liberty University in the Leadership Cognate.